Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Once infected we will always test positive for HCV antibodies.
What you should be concerned about is any viral load showing.
What was the positive referring to?
When you went under this number you were undetected. What i can tell you did 48 weeks whats mean you failed prior treatments so got an auto 48 weeks , or you had to be late responder over 4 weeks to achieve the undie stage. Now this was the general rule. Late respond mean more chance for the relapse. It helped if you were a CC with the IL28B test. CT didn't worked well with the treatment.
If the virus stayed under the 25 level, yes the majority of virus got killed but there was some what mutated , and unfortunately the treatment couldn't touch. Vertex lied as the real cure rate turned out to be 44% of the Incivek and 30% for the Victrelis.
The newer drugs the 3 generation work on people whom relapsed from the triple. If you did relapsed find a trial immediately end enroll to one.Yeah it still an option encase, but retest first we have seen false positives too. Either way you are not out of options what is a good thing. If you are positive it should have come with a viral count. Undie is means you test positive for the antibodies but no countable virus present in your blood. Todays standard test shows 5 IU/ml.
Call them tomorrow and ask for the viral , they should have given that to you, unless you got to go in for more test . Virus count takes 3 vial of blood i think . Good luck to you.
Virus quantification involves counting the number of viruses in a specific volume to determine the virus concentration. It is utilized in both research and development (R&D) in commercial and academic laboratories as well as production situations where the quantity of virus at various steps is an important variable. For example, the production of viral vaccines, recombinant proteins using viral vectors and viral antigens all require virus quantification to continually adapt and monitor the process in order to optimize production yields and respond to ever changing demands and applications. Examples of specific instances where known viruses need to be quantified include clone screening, multiplicity of infection (MOI) optimization and adaptation of methods to cell culture. This page discusses various techniques currently used to quantify viruses in liquid samples. These methods are separated into two categories, traditional vs. modern methods. Traditional methods are industry-standard methods that have been used for decades but are generally slow and labor intensive. Modern methods are relatively new commercially available products and kits that greatly reduce quantification time. This is not meant to be an exhaustive review of all potential methods, but rather a representative cross-section of traditional methods and new, commercially available methods. While other published methods may exist for virus quantification, non-commercial methods are not discussed here.
This is the test what the doctor should have ordered? and not the one for the antibodies......so who knows....